Package 43602-544-90

{"route": ["ORAL"], "spl_id": "97d403fb-8a67-483d-8f9c-45dd16a31689", "openfda": {"nui": ["N0000000151", "N0000175784", "N0000000160", "M0001335", "N0000175722"], "upc": ["0343602544306"], "unii": ["5QZO15J2Z8", "WK2XYI10QM"], "spl_set_id": ["03733e49-7db4-4d98-b363-d0d23686ec72"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]", "Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Ascent Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (43602-544-05)", "package_ndc": "43602-544-05", "marketing_start_date": "20221006"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (43602-544-30)", "package_ndc": "43602-544-30", "marketing_start_date": "20221006"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (43602-544-90)", "package_ndc": "43602-544-90", "marketing_start_date": "20221006"}], "brand_name": "IBUPROFEN AND FAMOTIDINE", "product_id": "43602-544_97d403fb-8a67-483d-8f9c-45dd16a31689", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "43602-544", "generic_name": "Ibuprofen and famotidine", "labeler_name": "Ascent Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "IBUPROFEN AND FAMOTIDINE", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "26.6 mg/1"}, {"name": "IBUPROFEN", "strength": "800 mg/1"}], "application_number": "ANDA216814", "marketing_category": "ANDA", "marketing_start_date": "20221006", "listing_expiration_date": "20261231"}